Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:1190-1194 (8 December), doi:10.1136/bmj.39402.463854.AE (published 30 November 2007)
Lourdes Mahilum-Tapay, director of scientific affairs1, Vivian Laitila, director of regulatory affairs1, James J Wawrzyniak, research assistant2, Helen H Lee, reader in medical biotechnology2, Sarah Alexander, clinical scientist3, Catherine Ison, director3, Alison Swain, senior doctor4, Penelope Barber, chief executive officer4, Ines Ushiro-Lumb, virologist5, Beng T Goh, consultant, genitourinary medicine clinics5
1 Diagnostics for the Real World (Europe) Ltd, Cambridge Science Park, Cambridge CB4 0WG, 2 University of Cambridge, Department of Haematology, Diagnostics Development Unit, EABC Site, Long Road, Cambridge CB2 2PT, 3 Sexually Transmitted Bacteria Reference Laboratory, Health Protection Agency Centre for Infections, London NW9 5HT, 4 Brook in Birmingham, 56-61 John Bright Street, Birmingham B1 1BL, 5 Barts and The London NHS Trust, London E1 1BB
Correspondence to: H H Lee hl207{at}cam.ac.uk
Design Performance evaluation study.
Settings A young peoples sexual health centre (site 1) and two genitourinary medicine clinics (sites 2 and 3) in the United Kingdom.
Participants 1349 women aged between 16 and 54 attending one of the three clinics.
Main outcome measures Sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test versus polymerase chain reaction and strand displacement amplification assays; correlation between the Chlamydia Rapid Test visual signal and organism load; acceptability to participants of self collected vaginal swabs as the specimen type for Chlamydia testing.
Results Polymerase chain reaction positivity rates for Chlamydia trachomatis infection were 8.4% (56/663) at site 1, 9.4% (36/385) at site 2, and 6.0% (18/301) at site 3. Compared with polymerase chain reaction assay, the resolved sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test were 83.5% (91/109), 98.9% (1224/1238), 86.7% (91/105), and 98.6% (1224/1242). Compared with strand displacement amplification assay, sensitivity and specificity of the Chlamydia Rapid Test were 81.6% (40/49) and 98.3% (578/588). Organism load of self collected vaginal swabs ranged from 5.97x102 to 1.09x109 Chlamydia plasmids per swab, which correlated well with the Chlamydia Rapid Tests visual signal (r=0.6435, P<0.0001). Most (95.9%) surveyed participants felt comfortable about collecting their own swabs.
Conclusions The performance of the Chlamydia Rapid Test with self collected vaginal swabs indicates that it would be an effective same day diagnostic and screening tool for Chlamydia infection in women. The availability of Chlamydia Rapid Test results within 30 minutes allows for immediate treatment and contact tracing, potentially reducing the risks of persistent infection and onward transmission. It could also provide a simple and reliable alternative to nucleic acid amplification tests in chlamydia screening programmes.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses